Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 9 Expanded_access 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 32 Multiple Myeloma 26 Neoplasms 25 Recurrence 23 Melanoma 19 Leukemia, Myeloid, Acute 16 Breast Neoplasms 15 Prostatic Neoplasms 12 Pancreatic Neoplasms 11 Glioblastoma 11 Sarcoma 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lung Neoplasms 9 Ovarian Neoplasms 8 Lymphoma 8 Glioma 8 Colorectal Neoplasms 8 Small Cell Lung Carcinoma 7 Lymphoma, Large B-Cell, Diffuse 7 Carcinoma, Renal Cell 7 Lymphoma, Non-Hodgkin 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Gastrointestinal Stromal Tumors 6 Cholangiocarcinoma 6 Triple Negative Breast Neoplasms 5 Stomach Neoplasms 5 Neoplasm Metastasis 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Thyroid Neoplasms 4 Lymphoma, Mantle-Cell 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Expanded_access × Desmoid Tumors × Clear all

NCT05041036 2026-05-08

Individual Patient Compassionate Use of Nirogacestat

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡